Amarin Probability Of Bankruptcy

$2.24  0.0060  0.27%
       
For stocks, Probability Of Bankruptcy is normalized value of Z-Score. For funds and ETFs it is derived from a multi-factor model developed by Macroaxis.The score is used to predict probability of a firm or a fund going into bankruptcy or experiencing financial distress within next 24 months. Unlike Z-Score, Probability Of Bankruptcy is the value between 0 and 100 indicating the actual probability the firm will be distressed in the next 2 fiscal years.
Amarin 
Probability Of Bankruptcy 
 = 
Normalized 
 
Z-Score 
 = 
92.0 %

About Probability Of Bankruptcy

Companies or funds with Probability Of Bankruptcy above 90% are generally considered to be high risk with a good chance of bankruptcy in the next 2 years. On the other hand entities with Probability Of Bankruptcy of less than 15% will most likely experience some growth in the next 2 years. Probability Of Bankruptcy is based on Macroaxis own algorithm and can be used by auditors, accountants, money managers, financial advisers, as well as day traders to evaluate unsystematic risk of a stock, fund or ETF.
Compare Amarin to competition

Amarin Probability Of Bankruptcy Assessment

Of Bankruptcy  
Benchmark  Embed   Amarin Comparables 
Based on latest financial disclosure Amarin Corporation plc has Probability Of Bankruptcy of 92%. This is 127.39% higher than that of the Healthcare sector, and 53.72% higher than that of Drug Manufacturers - Other industry, The Probability Of Bankruptcy for all stocks is 114.0% lower than the firm.
ETFsFundsStocks

Filter other Stocks by Probability Of Bankruptcy

Probability Of Bankruptcy Input Range 
Industry  
Click to run this filter
Filter Other Equities
  
Found 10 equities

Probability Of Bankruptcy

NVO NYQNovo Nordisk AS
1.0%
TEVA NYQTeva Pharmaceutical Industries Limited
28.91%
ENDP NMSEndo International plc
39.01%
RDY NYQDr Reddys Laboratories Ltd
1.0%
UTHR NMSUnited Therapeutics Corporation
1.0%
ISIS NMSIsis Pharmaceuticals Inc
14.77%
TARO NYQTaro Pharmaceutical Industries Ltd
1.0%
DEPO NMSDepoMed Inc
42.9%
SCMP NGMSucampo Pharmaceuticals Inc
4.21%
AMPH NMSAmphastar Pharmaceuticals Inc
6.1%
You can backtest this sub-set of assets as a synthetic portfolio or check its risk adjusted returns  

Chance of Financial Distress

Amarin Corporation plc has more than 91 (%) percent chance of experiencing financial distress in the next 2 years of operations. More Info
SymbolAMRN
ISINUS0231112063
CUSIP023111206
NameAmarin Corporation plc
InstrumentUSA Stock
Analyst ConsensusBuy 3 Opinions
Risk-adjusted AdviceStrong Buy Under Valued
CurrencyUSD - US Dollar
ExchangeNASDAQ General Markets
DescriptionAmarin Corporationration plc a biopharmaceutical company focuses on developing and commercializing therapeutics for the treatment of cardiovascular diseases in the United States. more

Other Amarin Fundamentals

Return On Asset(27.96) %
Profit Margin(103.96) %
Operating Margin(164.67) %
Current Valuation482.04 M
Shares Outstanding176.96 M
Shares Owned by Insiders3.93 %
Shares Owned by Institutions33.30 %
Number of Shares Shorted23.26 M
Price to Earning291.00 times
Price to Book341.94 times
Price to Sales7.03 times
Revenue59.17 M
Gross Profit33.72 M
EBITDA(96.6 M)
Net Income(62.38 M)
Cash and Equivalents161.2 M
Cash per Share0.91 times
Total Debt227.38 M
Current Ratio4.46 times
Book Value Per Share(0.50) times
Cash Flow from Operations(57.46 M)
Short Ratio14.20 times
One Year High3.33
One Year Low0.78
Earnings Per Share(0.39) times
Price to Earnings To Growth(0.04) times
Number of Employees201
Beta0.03
Market Capitalization405.24 M
Total Asset215.34 M
Retained Earnings(1 B)
Working Capital147.22 M
Current Asset189.75 M
Current Liabilities42.53 M
Z Score-5.0